Moreover, research and innovation are tied closely to professional achievement at academic centers. At the individual level, the ability to obtain funding and complete groundbreaking projects is often considered for recruitment and promotion. 5, 6 At the institutional level, laying the foundation for innovation garners multi-institutional collaboration and provides competitive advantages in the clinical market share. 7 For departments of surgery within the United States, the most broadly recognized measure of academic achievement is consistent funding support through the National Institutes of Health (NIH). 8 During the past decade, the adjusted NIH budget has decreased to its lowest point in 13 years. 9, 10 Surgeon-scientists who have had traditionally a lesser volume of NIH award applications and lesser success rate of their applications have been especially affected. [11] [12] [13] A part of this trend may be attributable to increasing clinical and administrative responsibilities in an era of resident work-hour restrictions and stringent outcomes reporting. 14 Consequently, many institutions are turning to dedicated PhD personnel to contribute to research endeavors. 15 Nevertheless, there remain many incentives that support the cultivation of a consistent physicianscientist workforce. The share of US medical research support attributable from industry is increasing. These industry funders are gradually shifting away from basic science research toward late-phase clinical trials. 16 In the public sector, the NIH is an especially efficient springboard for clinical inventions. Products developed through the NIH have a high rate of attaining orphan drug status and priority review by the Food and Drug Administration. 17 There remains, however, a constant need to refocus the NIH toward clinically relevant pursuits---a need filled most appropriately by practicing physicians. Thus far, no study has stratified national research contributions within surgery across clinical MDs, nonclinical MDs, and PhDs. In light of this, the purpose of this study was to characterize NIH-funded researchers within departments of surgery across the United States.
By comparing the recipients of NIH funding in the years 2003 and 2013, we sought to provide insight into factors that contribute to a consistently successful academic surgery department. We hypothesized that the number of junior faculty---assistant and associate professors---obtaining independent NIH awards have decreased and that successful academic departments of surgery are depending increasingly on PhD faculty.
METHODS
Using previously reported methods of data collection, 18 the NIH RePORTER database (Research Portfolio Online Reporting Tool [http://report. nih.gov]) was queried for all active research project grants within the United States and territories during the fiscal years of 2003 and 2013. The "Department" search field was used to identify grants allocated to departments of surgery. Because the project focused on faculty research, F and T awards were excluded, because these represent resident and student training grants.
As the purview of surgery departments varies across institutions, only grants allocated to core surgical disciplines were retained; thus, we excluded grants awarded to divisions of neurosurgery, orthopedics, otolaryngology, ophthalmology, urology, and gynecology. Grants were included regardless of the advanced degree of the principal investigator (MD, PhD, etc). The exported data included summary descriptions of research, total costs, and investigator information. For each grant, only the principal investigator was recorded in our data set. Total costs of grants were adjusted to 2013 equivalent dollars using an inflation adjustment factor of 1.27.
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The protocol used to categorize NIH grants by methodology has been reported previously. 18 Briefly, research summary descriptions for all grants were reviewed by 1 of 2 study investigators (Y. H., B. E.). Each investigator reviewed grants from both data sets (2003 and 2013) . Based on these descriptions, the primary methodology for each grant was classified into 1 of 6 categories: basic science, translational, clinical trial, outcomes, operative technique, and other. Projects that incorporated several methodologies were classified as translational. A total of 150 grants were reviewed by both reviewers to assess inter-rater agreement (0.85); all disagreements originated from the differentiation between basic science and translational research.
The academic position and advanced degree (MD versus PhD) of the principal investigator for each NIH grant was extracted from the NIH RePORTER investigator description page. When these data were not immediately available, investigator curricula vitae or professional biographies were acquired through an online search, and the academic position of the investigator at the time of funding was recorded. Among MD researchers, those who did not have an active clinical practice were designated as nonclinical MD researchers. Faculty with both MD and PhD degrees were classified as clinically active MDs if they were practicing clinicians or as PhDs if they held a research position only.
Departments of surgery were ranked by total number of active NIH grants in 2003 and in 2013. Proportional composition of MDs and PhDs was compared among the top 20 surgery departments and all remaining surgery departments using the v 2 test. Due to overlap in principal investigators between 2003 and 2013, tests of statistical significance between these 2 data sets were not performed.
RESULTS
We identified 1,125 grants (613 from 2003 and 512 from 2013) that met inclusion criteria.
Inflation-adjusted NIH funding to surgical research decreased by 19.1% from $270.4 million in 2003 to $218.7 million in 2013. Details regarding trends in funding across methodologic and specialty subgroups have been reported previously. 18 In 2013, the majority of active surgery grants were funded through the National Cancer Institute (27%); National Heart, Lung, and Blood Institute (25%); and the National Institute of Diabetes and Digestive and Kidney Diseases (18%).
Nearly half of active grants resulted from review by special emphasis panels (44%), while other top study sections included surgery, anesthesiology and trauma (11%), bioengineering, technology and surgical sciences (8%), and the Subcommittee on Education through the National Cancer Institute (3%). The total number of principal investigators within departments of surgery funded through the NIH decreased 4.5% (433 to 412; Table I ). The proportion of MD and PhD investigators remained relatively constant, but PhD investigators contributed to an increasing proportion of total NIH surgical research funding (34% to 47%). This increase was due to a greater decrease in funding per investigator among MD investigators compared to that of PhDs.
Information about academic position was not available for 2 investigators (1 clinically active MD) from 2013 (0.5%) and 24 investigators (12 clinically active MDs) from 2003 (5.6%). Among investigators with known faculty rank, the proportion of funded MD investigators who were junior faculty---associate or assistant professors---doubled from 19.8% (50/252) to 38.8% (90/232; Table I ). Junior faculty were awarded less funding per investigator than senior faculty in both periods; however, this gap narrowed in 2013 (Table II) . Translational and basic science projects dominated during both periods for investigators at all levels of rank (Table II) . Nevertheless, outcomes research increased, comprising 4.2% of projects in 2003 and 12% in 2013.
To understand better the evolution of MD and PhD investigators within departments of surgery, we focused on those investigators funded in 2013 who were not previously funded in 2003 (Table III) . Among these newly funded investigators, 40.5% were PhDs. More than half of all newly funded MD investigators were junior faculty (52.6%) and most were trained in a clinical subspecialty (80.5%). Despite a trend in proportional increase of outcomes-based projects (14.3%), the majority of research performed by these newly funded investigators remains within the areas of basic and translational sciences (74.7%). Among investigators funded in both 2013 and 2003, 97/133 (72.9%) had an R-type grant in 2013 (78.4% R01, 11.3% R21, 4% R25, 6% other). Notably, 29 (22%) of these investigators changed institutions over the study period.
Our final aim was to characterize the patterns of personnel within surgery departments that have had durable success in research. 
DISCUSSION
Throughout the past decade, an increasing proportion of NIH-funded research conducted within departments of surgery has been contributed by PhD investigators. In terms of funding per investigator, PhDs outperformed MD counterparts. The highest-performing surgery departments are those that maintained a 2-to-1 ratio of MD to PhD investigators. Unexpectedly, but encouragingly, the contribution to MD-led research by junior clinical faculty has increased over time.
As early as the 1970s, it was noted that basic scientists within clinical departments attained some of the greatest rates of NIH grant awards. 20 PhD investigators frequently have expansive experience in study design and grant writing and a broad, handson skillset in basic science. Despite these advantages, PhDs in clinical departments are less likely to be promoted and less likely to pursue a tenure track than clinicians. 21 Between the 1970s and 1990s, the number of PhDs on faculty at medical schools doubled. 15 By 1999, PhDs accounted for more than half of NIH-funded investigators across a number of specialties, including surgery.
Our data capturing the years 2003 and 2013 show that, within core surgical disciplines of the 21st century, clinical MDs comprise the majority of NIH-funded investigators. This finding could indicate that the demographic of clinically active surgeon-scientists is experiencing a rebirth. Indeed, the increasing proportion of junior MD investigators supports this explanation. An alternative reason could be that certain subspecialties not included in our data set---such as neurosurgery, orthopedics, and ophthalmology---may have a greater proportion of PhD investigators than the classic divisions of a department of surgery.
As medical knowledge continues to expand, the real-world relevance of new discoveries requires constant refocusing. The surgeon-scientist is positioned uniquely to interpret data and pose new questions. 22 Among the consistently highestranking surgical departments in grants awarded, a 2-to-1 ratio of MD to PhD principal investigators was evident in both 2003 and 2013. This ratio may be a target worth considering for surgery departments that desire to grow their research endeavors.
The former NIH director, James Wyngaarden, noted in 1979 a precipitous decrease in MDs engaged in postdoctoral training supported by the NIH. The same trend was reflected in funding directed toward junior clinical faculty. 23 Even as the NIH expanded in the 1980s and 1990s, the proportion of research grants awarded to MDs continued to decrease as did the number of firsttime MD applicants. 22 While the success rate of NIH applications by MDs during the 1970s to 1990s was comparable to that for PhDs, more recent work has shown that applications from surgeons have had less success rates and funding costs than medical and PhD counterparts. 12 Surgeon-scientists face certain disadvantages compared with nonsurgeon counterparts. The ratio of NIH study section members to grant submissions is less for surgery than for other specialties, thereby decreasing the rate of true peer review. 13 This decrease may hinder the success of funding for surgeons, particularly for patient-oriented research. 24 Because the salary packages for surgeons are typically reliant on operative volume, there also exists a heavier opportunity cost for time dedicated to grant writing. 25 This factor is more relevant now than ever, as decreases in procedural reimbursements have lead surgeons to strive for greater clinical productivity 11 and resident work-hour restrictions have shifted more clinical responsibilities to faculty. 14 Because the strongest predictor of a successful NIH proposal is previous NIH funding, 26 the above factors should disproportionately hinder first-time applicants and junior surgeons. Indeed, there has been a steady decrease in first-time applicants, fellowship awards, and K08 awards between the 1980s and 2011. 27 Our results indicate that today's young surgeonscientists are thriving in the face of these challenges. Despite a lesser average amount of funding per investigator than senior faculty, the total funding amount contributed by junior surgeons has nearly doubled between 2003 and 2013. Importantly, the increase in funded junior surgeons is not limited to K awards alone. In fact, the number of junior surgeons with R awards has nearly tripled. More than half of all MDs funded in 2013 who were not funded previously in 2003 were assistant or associate professors. Moving forward, senior surgical faculty should continue to nurture this evolution. This is exemplified by our finding that among the 20 institutions with the most NIH grants in 2013, nearly half were led by departmental chairs who were themselves funded through the NIH.
Policy changes within the NIH in 2007 have increased the success rate of applications for firsttime applicants. 28 Efforts must be made to bolster every phase of the research pipeline to take full advantage of this opportunity. Identification of future surgeon-scientists should begin with students and residents. Opportunities for master's or PhD degrees should be offered to aspiring scientists. One of the strongest predictors of academic productivity among faculty is the number of publications generated during residency. 29, 30 With the aim of augmenting publication throughput, didactics addressing basic statistics, experimental design, epidemiology, and grantsmanship are as integral to the education of junior residents as pathophysiology.
For junior faculty enrolled on research tenure tracks, courses should be offered that focus on essential research skills, such as time allocation, collaboration, grant writing, and budget management. Because attainment of a K award doubles effectively the likelihood for future R01 funding, 31 a team of mentors should be assigned to each new investigator to proctor the process of first obtaining a K08, K23, or equivalent training award. There should be efforts to lobby the NIH to alter K-award requirements, such that their requisite time commitments can be decreased in exchange for an extended duration of the award and a lesser annual cost. Most important, departmental policies regarding protected time and resources for research must reflect the academic mission of the institution.
This study has several limitations. Only data from the fiscal years of 2003 and 2013 were accrued. Assessing data from each year spanning this period would create a more rigorous depiction of trends; however, such a task would require the review of more than 5,000 grant summaries. Accruing data only from these 2 fiscal years also avoided confounders from the American Recovery and Reinvestment Act, which was responsible for an aberrant influx of NIH funding in 2009.
Because the roster of principal investigators from 2003 and 2013 were not mutually independent, statistical comparisons could not be made between these 2 years. To address this, we provided details on previously unfunded investigators in order to generate indirect insight into the directionality of change among research personnel. Further, because only the principal investigator for each grant was accounted for within our data set (no co-principal investigators or coinvestigators), our outcomes may underestimate the full breadth of research involvement among surgical faculty in the United States. This underestimate may be particularly true for junior faculty who are more likely to be involved as coinvestigators during the early stages of their research careers.
There is no doubt that PhD investigators comprise a vital component of the surgery research engine. Within core surgical disciplines, however, surgeon-scientists continue to comprise the majority of NIH-funded investigators in departments of surgery. The most consistently successful research departments maintain a stable faction of NIH-funded, clinically active surgeons. Conversely, departments that fail to accomplish this faction of surgeon-scientists are liable to descend from the elite tier.
Encouragingly, the proportion of these surgeonscientists that are junior faculty is expanding, foretelling hopefully a durable future for surgical research. In an era of continued NIH budgetary stagnation, national and institutional policies aimed at nurturing new researchers will be valuable to preserve this momentum.
